Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2025-12-24 @ 2:51 PM
NCT ID:
NCT03851159
Eligibility Criteria:
Inclusion Criteria:
* 18-65 years
* New cases
* Sputum Xpert Ultra (Xpert) positive for Mycobacterium tuberculosis
* Have not initiated TB treatment
* If HIV-positive, are stable on antiretroviral therapy
Exclusion Criteria:
* Resistance to any of the first-line drugs (Xpert rifampicin-resistant)
* Previous TB
* Diabetes mellitus
* Taking immunomodulatory drugs (e.g. cancer chemotherapy, tumour necrosis factor (TNF) inhibitors or other anti-inflammatory medication, phosphodiesterase inhibitors, corticosteroids within the past 6 months, and cholesterol-lowering drugs)
* Pregnant or lactating women
* Chronic hepatitis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03851159
Study Brief:
Protocol Section:
NCT03851159